Terms: = Prostate cancer AND SS18, Q15532, 6760, ENSG00000141380, SSXT, SYT
13 results:
1. The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the prostate (TURP).
Liu J; Pan S; Dong L; Wu G; Wang J; Wang Y; Qian H; Dong B; Pan J; Zhu Y; Xue W
Curr Oncol; 2022 Sep; 29(9):6373-6382. PubMed ID: 36135071
[TBL] [Abstract] [Full Text] [Related]
2. Mesenchymal Neoplasms of the prostate and Seminal Vesicles: Spectrum of Disease with Radiologic-Pathologic Correlation.
Marcal LP; Surabhi VR; Ramani NS; Katabathina VS; Paspulati RM; Prasad SR
Radiographics; 2022; 42(2):417-432. PubMed ID: 35030067
[TBL] [Abstract] [Full Text] [Related]
3. prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology.
Shan Y; Chen X; Liu K; Zeng M; Zhou J
Abdom Radiol (NY); 2019 Oct; 44(10):3441-3452. PubMed ID: 31144091
[TBL] [Abstract] [Full Text] [Related]
4. Primary malignant peripheral nerve sheath tumor of prostate in a young adult: A case report.
Kim H; Kim DY; Seol YM; Ku JY; Choi KU; Choi YJ
Medicine (Baltimore); 2018 Sep; 97(39):e12040. PubMed ID: 30278486
[TBL] [Abstract] [Full Text] [Related]
5. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
Alpsoy A; Dykhuizen EC
J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
[TBL] [Abstract] [Full Text] [Related]
6. Primary Intraprostatic Synovial Sarcoma.
Olofson AM; Linos K
Arch Pathol Lab Med; 2017 Feb; 141(2):301-304. PubMed ID: 28134577
[TBL] [Abstract] [Full Text] [Related]
7. Fine-needle aspiration biopsy of prostate synovial sarcoma: A case report and review of the literature.
Maleki S; Cajigas A; Moss J; Ramesh KH; Khader S
Diagn Cytopathol; 2017 Feb; 45(2):168-172. PubMed ID: 27774755
[TBL] [Abstract] [Full Text] [Related]
8. Histone deacetylase inhibitors reverse ss18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
Lubieniecka JM; de Bruijn DR; Su L; van Dijk AH; Subramanian S; van de Rijn M; Poulin N; van Kessel AG; Nielsen TO
Cancer Res; 2008 Jun; 68(11):4303-10. PubMed ID: 18519690
[TBL] [Abstract] [Full Text] [Related]
9. Primary synovial sarcoma of the prostate: report of 2 cases and literature review.
Jun L; Ke S; Zhaoming W; Linjie X; Xinru Y
Int J Surg Pathol; 2008 Jul; 16(3):329-34. PubMed ID: 18387992
[TBL] [Abstract] [Full Text] [Related]
10. S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study.
Ludwig S; Stephan C; Lein M; Loening SA; Jung K
Prostate; 2007 Sep; 67(12):1301-7. PubMed ID: 17626245
[TBL] [Abstract] [Full Text] [Related]
11. Molecularly confirmed primary prostatic synovial sarcoma.
Fritsch M; Epstein JI; Perlman EJ; Watts JC; Argani P
Hum Pathol; 2000 Feb; 31(2):246-50. PubMed ID: 10685642
[TBL] [Abstract] [Full Text] [Related]
12. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
Moffatt KA; Johannes WU; Miller GJ
Clin Cancer Res; 1999 Mar; 5(3):695-703. PubMed ID: 10100724
[TBL] [Abstract] [Full Text] [Related]
13. Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
Hedlund TE; Moffatt KA; Uskokovic MR; Miller GJ
Clin Cancer Res; 1997 Aug; 3(8):1331-8. PubMed ID: 9815816
[TBL] [Abstract] [Full Text] [Related]
